Alix Hampson

Alix Hampson has diverse experience in bioanalysis, most recently serving as Head of Bioanalysis at Pharmidex in February 2025. Prior roles include Principal Scientist - Bioanalysis and Bioanalysis Scientist at the CRUK-MRC Oxford Institute for Radiation Oncology, University of Oxford, where responsibilities involved analyzing pre-clinical and clinical trial samples, developing novel methods, and employing various extraction techniques and chromatography for small molecule analysis. Earlier experience includes positions as Bioanalyst, Study Director, and Senior Bioanalyst at ABS Laboratories, where Alix conducted drug analysis using LC-MS/MS and GC-NPD methods, ensured quality compliance in validation studies, and managed laboratory organization and deadlines per regulatory guidelines.